Author:
Yu Hung-Man,Chiu Ching-Hung,Chen Wei-Ting,Wu Chi-Han,Lin Pei-Yao,Huang Ya-Yao,Chen Jyun-Hong,Tzen Kai-Yuan,Shiue Chyng-Yann,Lin Wuu-Jyh
Funder
Atomic Energy Council (Taiwan)
Department of Nuclear Medicine
NTUH
National Taiwan University
Reference34 articles.
1. Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice;Beumer;Cancer Chemother. Pharmacol.,2008
2. Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2’-deoxycytidine in mice;Beumer;Clin. Cancer Res.,2006
3. Tumor-selective metabolism of 5-fluoro-2’-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma;Boothman;Cancer Res.,1987
4. Evaluation of 131/123I-5-iodo-2′-deoxycytidine as a novel proliferation probe in a tumor mouse model;Chang;Appl. Radiat. Isot.,2013
5. Reproducibility of the kinetic analysis of 3’-deoxy-3’-[(18)F]fluorothymidine positron emission tomography in mouse tumor models;Choi;Nucl. Med. Biol.,2009
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献